What is the current Price Target for the Cogent Biosciences Inc stock?

The average Cogent Biosciences Inc target price is $56.10. This is 69.03% higher than the current stock price. The highest price target is 89.82%, the lowest is 36.94%. 13 Analysts have issued a price target Cogent Biosciences Inc 2027 .

How high will the Cogent Biosciences Inc stock rise?

No reliable answer can be given as to how high the Cogent Biosciences Inc stock will rise. The performance of stocks, including the Cogent Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cogent Biosciences Inc stock today?

The performance of Cogent Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cogent Biosciences Inc stock fall?

The decline in Cogent Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cogent Biosciences Inc Forecast, price target & analysts

$33.19

2.00%

Nasdaq, Sep 17, 04:00 pm EDT. Closed.

ISIN

US19240Q2012

Symbol

COGT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Cogent Biosciences Inc Target price 2026 - Analyst rating & recommendation

Cogent Biosciences Inc Classifications & Recommendation

Buy

89%

Hold

11%

Cogent Biosciences Inc Price Target

Target Price	$56.10
Price	$33.19
Potential	69.03% register free of charge
Number of Estimates	13

	13 Analysts have issued a price target Cogent Biosciences Inc 2027 . The average Cogent Biosciences Inc target price is $56.10. This is 69.03% register free of charge higher than the current stock price. The highest price target is $63.00 89.82% register free of charge , the lowest is $45.45 36.94% register free of charge .
	A rating was issued by 18 analysts: 16 Analysts recommend Cogent Biosciences Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cogent Biosciences Inc stock has an average upside potential 2027 of 69.03% register free of charge . Most analysts recommend the Cogent Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative
EV/Sales		421.73

13 Analysts have issued a Cogent Biosciences Inc forecast for earnings per share. The average Cogent Biosciences Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-0.95 58.87% unlock
2028	$0.65 168.42% unlock
2029	$2.02 210.77% unlock
2030	$3.41 68.81% unlock
2031	$5.00 46.63% unlock
2032	$5.97 19.40% unlock
2033	$7.12 19.26% unlock

Current	-16.77	135.83%
2026	-14.10 15.94% unlock
2027	-34.33 143.48% unlock
2028	50.34 246.64% unlock
2029	16.10 68.02% unlock
2030	9.54 40.75% unlock
2031	6.50 31.87% unlock
2032	5.45 16.15% unlock
2033	4.57 16.15% unlock

Cogent Biosciences Inc...

Current Cogent Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Piper Sandler	Locked ➜ Locked	Locked	Aug 17 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 12 2026
Wedbush	Locked ➜ Locked	Locked	May 29 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 06 2026
Wedbush	Locked ➜ Locked	Locked	Mar 17 2026
Piper Sandler	Locked ➜ Locked	Locked	Feb 18 2026
Wedbush	Locked ➜ Locked	Locked	Jan 21 2026

Analyst Rating	Date
Locked Piper Sandler: Locked ➜ Locked	Aug 17 2026
Locked Guggenheim: Locked ➜ Locked	Aug 12 2026
Locked Wedbush: Locked ➜ Locked	May 29 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 06 2026
Locked Wedbush: Locked ➜ Locked	Mar 17 2026
Locked Piper Sandler: Locked ➜ Locked	Feb 18 2026
Locked Wedbush: Locked ➜ Locked	Jan 21 2026

Discover more stocks with a high price target

NIO ADR 102.31%

Alibaba Group Holding Ltd 75.49%

Infineon 69.69%

Rheinmetall 60.60%

Tencent Holdings Ltd. 60.42%

TUI 52.29%

Siemens Energy 47.46%

Adyen 47.42%

Adidas 46.48%

Uber Technologies 45.36%

BYD 41.55%

NVIDIA 39.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now